Metabolism of genotoxic agents: halogenated compounds. 1984

H M Bolt

Most halogenated compounds showing genotoxicity do not themselves react with macromolecules but are transformed to reactive metabolites. In order to explain the widely different genotoxicities of halogenated ethylenes, the 'optimum stability' theory of epoxides has been developed recently. An epoxide must be reactive to alkylate DNA, but stable enough to reach the target from the place of its formation. Also, pharmacokinetic aspects are important in accounting for differences in genotoxicities of closely related compounds; examples are provided. Reactive metabolites may bind to proteins, to lipids and coenzymes, and to DNA, but binding to targets other than DNA is far more common than DNA alkylation. An example is provided by investigations on 2,2'-dichlorodiethyl ether from which chloroacetaldehyde is formed. In contrast to vinyl chloride, which generates chloroethylene oxide (chlorooxirane) as well as chloroacetaldehyde, this compound leads to extensive covalent protein binding of metabolites, but not to DNA binding.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006846 Hydrocarbons, Halogenated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with HALOGENS. Halogenated Hydrocarbons
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H M Bolt
December 2006, Bioorganic & medicinal chemistry letters,
H M Bolt
February 1978, Clinical toxicology,
H M Bolt
October 1972, California medicine,
H M Bolt
January 1991, Critical reviews in biotechnology,
H M Bolt
January 1990, Schriftenreihe des Vereins fur Wasser-, Boden- und Lufthygiene,
H M Bolt
January 1988, Revista espanola de anestesiologia y reanimacion,
H M Bolt
April 1985, Science (New York, N.Y.),
Copied contents to your clipboard!